Efficacy of CHA<sub>2</sub>DS<sub>2</sub>-VASc scores in predicting chronic kidney disease risk in patients treated in cardiac intensive care units.

Heliyon · 2024 · PMC11263721 · PMID 39044981

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may not be significantno p-value reported

Given that the signs and symptoms of CKD may not be significant until the disease has progressed, utilizing the CHA 2 DS 2 -VASc score can prompt clinicians to be vigilant regarding the potential for declining renal function in patients with high scores.

also in 2,774 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.